Can-Fite BioPharma Ltd.CANFNYSE
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR+11.4%
5Y CAGR-11.3%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+11.4%/yr
vs -33.8%/yr prior
5Y CAGR
-11.3%/yr
Recent acceleration
Acceleration
+45.2pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 6262.62 | +37.2% |
| 2023 | 4563.89 | -60.3% |
| 2022 | 11508.32 | +154.1% |
| 2021 | 4528.23 | -56.6% |
| 2020 | 10439.69 | -8.5% |
| 2019 | 11409.02 | -52.5% |
| 2018 | 23999.71 | +1.9% |
| 2017 | 23547.95 | -9.5% |
| 2016 | 26021.31 | +164.2% |
| 2015 | 9847.33 | - |